The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multitrial evaluation of progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in previously untreated extensive-stage small cell lung cancer (ES-SCLC): An Alliance-led analysis.
Nathan R. Foster
No relevant relationships to disclose
Lindsay A. Renfro
No relevant relationships to disclose
Steven E. Schild
No relevant relationships to disclose
Mary Weber Redman
No relevant relationships to disclose
Xiaofei F. Wang
No relevant relationships to disclose
Suzanne Eleanor Dahlberg
No relevant relationships to disclose
Keyue Ding
No relevant relationships to disclose
Penelope Ann Bradbury
No relevant relationships to disclose
Suresh S. Ramalingam
No relevant relationships to disclose
David R. Gandara
No relevant relationships to disclose
Everett E. Vokes
No relevant relationships to disclose
Alex A. Adjei
No relevant relationships to disclose
Sumithra J. Mandrekar
No relevant relationships to disclose